ACHV

3.23

2.87% 0.09

Pre-mercato: 3.24 0.01 +0.31%

Achieve Life Sciences Inc (ACHV)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ACHV Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$3.14

Aprire:

$3.1

Volume 24 ore:

504.19K

Relative Volume:

0.73

Capitalizzazione di mercato:

$171.97M

Reddito:

Utile/perdita netta:

$-54.65M

Rapporto P/E:

-2.4946

EPS:

-1.2948

Flusso di cassa netto:

$-49.47M

1 W Prestazione:

+11.76%

1M Prestazione:

-30.09%

6M Prestazione:

+1.25%

1 anno Prestazione:

+26.67%

Intervallo 1D:

$3.05

$3.32

Intervallo di 1 settimana:

$2.62

$3.32

Portata 52W:

$1.84

$6.025

Achieve Life Sciences Inc Stock (ACHV) Company Profile

Nome

Achieve Life Sciences Inc

Settore

Healthcare (1116)

Industria

Biotechnology (624)

Telefono

425-686-1500

Indirizzo

22722 29TH DR. SE, SEATTLE, BC

Dipendente

Cinguettio

Prossima data di guadagno

2026-03-24

Ultimi documenti SEC

ACHV's Discussions on Twitter

Compare ACHV vs VRTX, REGN, ARGX, ALNY, INSM

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ACHV Achieve Life Sciences Inc	3.23	171.97M	0	-54.65M	-49.47M	-1.2948
VRTX Vertex Pharmaceuticals Inc	438.71	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	761.85	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	746.42	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	318.85	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	162.43	35.01B	606.42M	-1.28B	-997.58M	-6.403

Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-25	Iniziato	Citizens JMP	Mkt Outperform
2025-08-21	Iniziato	H.C. Wainwright	Buy
2024-11-14	Iniziato	Rodman & Renshaw	Buy
2024-09-27	Iniziato	Raymond James	Strong Buy
2023-05-10	Reiterato	Maxim Group	Buy
2021-06-23	Iniziato	Oppenheimer	Outperform

Mostra tutto

Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie

Apr 05, 2026

Q3 2025 Achieve Life Sciences Inc Earnings Call Transcript - GuruFocus

Apr 05, 2026

Apr 04, 2026

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2025 earnings call transcript - MSN

Apr 04, 2026

Apr 03, 2026

Achieve Life Sciences flags FDA observations while pushing launch to 2027 for smoking cessation med - msn.com

Apr 03, 2026

Apr 02, 2026

ACHV Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026

Achieve Life Sciences Inc (SP4P.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 02, 2026

Apr 01, 2026

Achieve Life Sciences: The Recent Sell-Off Skews The Outcomes (NASDAQ:ACHV) - Seeking Alpha

Apr 01, 2026

Mar 31, 2026

Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect - Finviz

Mar 31, 2026

In 3,014 subjects, Caris blood test reached 99.2% specificity - stocktitan.net

Mar 31, 2026

Aug Analyst Calls: Will Achieve Life Sciences Inc benefit from government policyMarket Rally & Weekly Momentum Stock Picks - baoquankhu1.vn

Mar 31, 2026

Mar 30, 2026

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Mar 30, 2026

Mar 28, 2026

Achieve Life Sciences reports fourth-quarter results in line with expectations - MSN

Mar 28, 2026

Aug Macro: Whats the fair value of Achieve Life Sciences Inc stockStock Surge & Smart Allocation Stock Reports - baoquankhu1.vn

Mar 26, 2026

Analysts Are Bullish on Top Healthcare Stocks: KalVista Pharmaceuticals (KALV), Achieve Life Sciences (ACHV) - The Globe and Mail

Mar 26, 2026

Achieve Life Sciences: Maintaining 'Buy' On Upcoming PDUFA And Expansion Into Vaping Cessation - Seeking Alpha

Mar 26, 2026

Achieve Life Sciences publishes cytisinicline receptor study By Investing.com - Investing.com Canada

Mar 26, 2026

Achieve Life Sciences publishes cytisinicline receptor study - Investing.com

Mar 26, 2026

Achieve Life Sciences Flags FDA Observations While Pushing Launch To 2027 For Smoking Cessation Med - Benzinga

Mar 26, 2026

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 26, 2026

Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability - The Spec

Mar 26, 2026

Q1 Earnings Estimate for ACHV Issued By HC Wainwright - MarketBeat

Mar 26, 2026

Execution Risks Cloud Achieve Life Sciences’ Commercial Plans for Cytisinicline - The Globe and Mail

Mar 26, 2026

Mar 25, 2026

Achieve Life Sciences, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 25, 2026

HC Wainwright Reiterates "Buy" Rating for Achieve Life Sciences (NASDAQ:ACHV) - MarketBeat

Mar 25, 2026

H.C. Wainwright reiterates Buy on Achieve Life Sciences stock By Investing.com - Investing.com Canada

Mar 25, 2026

Achieve Life Sciences (ACHV): HC Wainwright & Co. Reiterates Buy Rating | ACHV Stock News - GuruFocus

Mar 25, 2026

Earnings Call Summary | Achieve Life(ACHV.US) Q4 2025 Earnings Conference - 富途牛牛

Mar 25, 2026

Mar 24, 2026

Achieve Life Sciences outlines first half 2027 cytisinicline launch supported by US manufacturing shift and AI-driven commercialization - MSN

Mar 24, 2026

Achieve Life Sciences stock falls as commercial launch pushed to 2027 - ca.investing.com

Mar 24, 2026